Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Other Non Operating Income came in at $76264.0 in Q1 2026, up 2785.51% year-on-year from $2643.0 in Q1 2025, and down 76.6% quarter-over-quarter from $325907.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $76264.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 2785.51% year-over-year to $76264.0 in Q1 2026; TTM through Mar 2026 was $416271.0, a 15.45% increase from a year earlier, with the FY2025 full-year figure at $342650.0, down 38.35% from the prior year.
- Other Non Operating Income slipped to $76264.0 in Q1 2026 per SHPH's latest filing, from $325907.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.2 million in Q1 2023 and bottomed at -$517687.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is $98313.0 (2023), against an average of $162795.8.
- Across the five-year window, Other Non Operating Income soared 3029.89% in 2023 and tumbled 133.11% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$517687.0 in 2022, then jumped by 118.99% to $98313.0 in 2023, then soared by 119.08% to $215384.0 in 2024, then soared by 51.31% to $325907.0 in 2025, then sank by 76.6% to $76264.0 in 2026.
- Per Business Quant, the three latest SHPH Other Non Operating Income figures stand at $76264.0 (Q1 2026), $325907.0 (Q4 2025), and $2427.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,264.00 |
| Dec 31, 2025 | 325,907.00 |
| Sep 30, 2025 | 2,427.00 |
| Jun 30, 2025 | 11,673.00 |
| Mar 31, 2025 | 2,643.00 |
| Dec 31, 2024 | 215,384.00 |
| Sep 30, 2024 | 286,316.00 |
| Jun 30, 2024 | -143,773.00 |
| Mar 31, 2024 | 197,862.00 |
| Dec 31, 2023 | 98,313.00 |
| Sep 30, 2023 | 442,900.00 |
| Jun 30, 2023 | 434,275.00 |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | -517,687.00 |
| Sep 30, 2022 | 112,797.00 |
| Jun 30, 2022 | -58,422.00 |
| Mar 31, 2022 | 39,650.00 |
| Sep 30, 2021 | 62,500.00 |